Orthofix Medical Inc.

Historical 13F Holders

Symbol
OFIX
CUSIP
68752M108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 68752M108 since 12/18/2024, newest first.

Filer % of Class Filed
Armistice Capital, LLC 13G/A Amendment 8
8.0% 8/14/2026
Event 6/30/2026
Juniper Investment Company, LLC 13D/A Amendment 5
11.0% 5/27/2026
Event 5/22/2026
Armistice Capital, LLC 13G/A Amendment 7
6.7% 5/15/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 7 0% 3/27/2026
Event 3/13/2026
Armistice Capital, LLC 13G/A Amendment 6
6.7% 2/17/2026
Event 12/31/2025
Juniper Investment Company, LLC 13D/A Amendment 4
9.6% 2/13/2026
Event 2/11/2026
Armistice Capital, LLC 13G/A Amendment 5
5.7% 11/14/2025
Event 9/30/2025
Juniper Investment Company, LLC 13D/A Amendment 3
8.2% 10/21/2025
Event 10/17/2025
Juniper Investment Company, LLC 13D/A Amendment 2
7.2% 9/25/2025
Event 9/23/2025
Armistice Capital, LLC 13G/A Amendment 3
7.6% 5/15/2025
Event 3/31/2025
Engine Capital, L.P. 13D/A Amendment 4
10.9% 5/8/2025
Event 5/7/2025
BlackRock, Inc. 13G/A Amendment 5 7.7% 4/17/2025
Event 3/31/2025
Juniper Investment Company, LLC 13D/A Amendment 1
6.1% 4/11/2025
Event 4/9/2025
Engine Capital, L.P. 13D/A Amendment 3
9.3% 2/27/2025
Event 2/25/2025
Armistice Capital, LLC 13G/A Amendment 2
7.9% 2/14/2025
Event 12/31/2024
Juniper Investment Company, LLC 13D
5.1% 1/7/2025
Event 12/30/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 5 15.8 k $143 k
2026 Q2 145 38.3 M $351 M
2026 Q1 149 36.0 M $413 M
2025 Q4 147 35.2 M $534 M
2025 Q3 149 35.5 M $520 M
2025 Q2 162 36.2 M $404 M
2025 Q1 166 33.3 M $543 M
2024 Q4 154 33.0 M $577 M
2024 Q3 155 34.8 M $544 M
2024 Q2 139 37.6 M $499 M
2024 Q1 145 41.4 M $601 M
2023 Q4 161 38.1 M $514 M
2023 Q3 161 34.2 M $439 M
2023 Q2 153 33.3 M $597 M
2023 Q1 164 32.6 M $546 M
2022 Q4 161 21.4 M $438 M
2022 Q3 147 19.8 M $378 M
2022 Q2 133 19.8 M $467 M
2022 Q1 152 19.4 M $635 M
2021 Q4 139 19.5 M $606 M
2021 Q3 144 22.2 M $846 M
2021 Q2 135 19.0 M $762 M
2021 Q1 143 19.9 M $844 M
2020 Q4 146 19.7 M $848 M
2020 Q3 139 18.8 M $586 M
2020 Q2 143 18.5 M $591 M
2020 Q1 149 18.5 M $519 M
2019 Q4 162 18.9 M $873 M
2019 Q3 162 18.5 M $981 M
2019 Q2 171 18.1 M $958 M
2019 Q1 185 18.6 M $1.05 B
2018 Q4 182 18.5 M $970 M
2018 Q3 171 19.2 M $1.11 B
2018 Q2 13 674 k $38.3 M
2018 Q1 1 173 $10.2 k